Category Health Tech

Petspan Unveils First Telemedicine Protocol with Rapamycin for Treating Feline Hypertrophic Cardiomyopathy

Petspan Unveils First Telemedicine Protocol with Rapamycin for Treating Feline Hypertrophic Cardiomyopathy

Petspan, the veterinary telemedicine division of longevity health company Healthspan, today announced the launch of the industry’s first remote-care protocol delivering rapamycin therapy to cats diagnosed with hypertrophic cardiomyopathy (HCM). Our HCM…

Read MorePetspan Unveils First Telemedicine Protocol with Rapamycin for Treating Feline Hypertrophic Cardiomyopathy
CorFlow Therapeutics Receives FDA Approval for MOCA-II Pivotal Trial of Innovative Heart Attack Treatment Technology

CorFlow Therapeutics Receives FDA Approval for MOCA-II Pivotal Trial of Innovative Heart Attack Treatment Technology

CorFlow Therapeutics AG  a pioneering company in the field of cardiac care targeting microvascular disease, today announced that the U.S. Food & Drug Administration (FDA) has approved the company’s technology for…

Read MoreCorFlow Therapeutics Receives FDA Approval for MOCA-II Pivotal Trial of Innovative Heart Attack Treatment Technology
Cancer Vaccine Market 2021–2031: Growth Driven by Precision Immunotherapy & Personalized Medicine

Cancer Vaccine Market 2021–2031: Growth Driven by Precision Immunotherapy & Personalized Medicine

The “Cancer Vaccine Market (2025 Edition): Analysis By Type (Preventative, Therapeutic), By Technology Type, By Region, By Country: Market Insights and Forecast (2021-2031)” report has been added to ResearchAndMarkets.com’s offering. The Global Cancer Vaccine…

Read MoreCancer Vaccine Market 2021–2031: Growth Driven by Precision Immunotherapy & Personalized Medicine
Alto Neuroscience Highlights Lancet Psychiatry Study on Pramipexole’s Benefits in Treatment-Resistant Depression

Alto Neuroscience Highlights Lancet Psychiatry Study on Pramipexole’s Benefits in Treatment-Resistant Depression

Alto Neuroscience, a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today highlighted The Lancet Psychiatry publication of data from the PAX-D study evaluating pramipexole in…

Read MoreAlto Neuroscience Highlights Lancet Psychiatry Study on Pramipexole’s Benefits in Treatment-Resistant Depression